Search Results - "FILLINGER, Janos"

Refine Results
  1. 1

    Current therapy of KRAS-mutant lung cancer by Ghimessy, Aron, Radeczky, Peter, Laszlo, Viktoria, Hegedus, Balazs, Renyi-Vamos, Ferenc, Fillinger, Janos, Klepetko, Walter, Lang, Christian, Dome, Balazs, Megyesfalvi, Zsolt

    Published in Cancer and metastasis reviews (01-12-2020)
    “…KRAS mutations are the most frequent gain-of-function alterations in patients with lung adenocarcinoma (LADC) in the Western world. Although they have been…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Inter- and intratumoral proteomics and glycosaminoglycan characterization of ALK rearranged lung adenocarcinoma tissues: a pilot study by Balbisi, Mirjam, Sugár, Simon, Schlosser, Gitta, Szeitz, Beáta, Fillinger, János, Moldvay, Judit, Drahos, László, Szász, A. Marcell, Tóth, Gábor, Turiák, Lilla

    Published in Scientific reports (17-04-2023)
    “…Lung cancer is one of the most common types of cancer with limited therapeutic options, therefore a detailed understanding of the underlying molecular changes…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma by Gyulai, Marton, Harko, Tunde, Fabian, Katalin, Karsko, Luca, Agocs, Laszlo, Szigeti, Balazs, Fillinger, Janos, Szallasi, Zoltan, Pipek, Orsolya, Moldvay, Judit

    Published in Pathology oncology research (09-08-2023)
    “…Background: Although the expression of tight junction protein claudins (CLDNs) is well known in common histological subtypes of lung cancer, it has not been…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited by Abdelwahab, ElHusseiny M. M., Bovari-Biri, Judit, Smuk, Gabor, Fillinger, Janos, McPhail, Donald, Krymskaya, Vera P., Pongracz, Judit E.

    Published in Apoptosis (London) (01-06-2021)
    “…Tuberous sclerosis, angiomyolipoma and lymphangioleiomyomatosis are a group of diseases characterized by mutation in tuberous sclerosis genes (TSC 1-2). TSC…”
    Get full text
    Journal Article
  14. 14
  15. 15

    PD-1 and PD-L1 expression in rare lung tumors by Gyulai, Marton, Megyesfalvi, Zsolt, Reiniger, Lilla, Harko, Tunde, Ferencz, Bence, Karsko, Luca, Agocs, Laszlo, Fillinger, Janos, Dome, Balazs, Szallasi, Zoltan, Moldvay, Judit

    Published in Pathology oncology research (18-05-2023)
    “…Our knowledge is still limited about the characteristics and treatment of rare lung tumors. The aim of our study was to determine programmed cell death…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The landscape of small cell lung cancer metastases: Organ specificity and timing by Megyesfalvi, Zsolt, Tallosy, Bernadett, Pipek, Orsolya, Fillinger, Janos, Lang, Christian, Klikovits, Thomas, Schwendenwein, Anna, Hoda, Mir Alireza, Renyi‐Vamos, Ferenc, Laszlo, Viktoria, Rezeli, Melinda, Moldvay, Judit, Dome, Balazs

    Published in Thoracic cancer (01-03-2021)
    “…Background Early metastasis is a hallmark of small cell lung cancer (SCLC). However, the mechanisms and resulting patterns of SCLC dissemination are unclear…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Lymphangiogenesis Correlates with Lymph Node Metastasis, Prognosis, and Angiogenic Phenotype in Human Non–Small Cell Lung Cancer by RENYI-VAMOS, Ferenc, TOVARI, Jozsef, FILLINGER, Janos, TIMAR, Jozsef, PAKU, Sandor, KENESSEY, Istvan, OSTOROS, Gyula, AGOCS, Laszlo, SOLTESZ, Ibolya, DOME, Balazs

    Published in Clinical cancer research (15-10-2005)
    “…Purpose: Recent experimental studies have revealed that lymphangiogenesis plays an important role in cancer progression, but its clinical significance in the…”
    Get full text
    Journal Article
  20. 20